docetaxel anhydrous has been researched along with bergamottin in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (bergamottin) | Trials (bergamottin) | Recent Studies (post-2010) (bergamottin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 104 | 6 | 51 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | bergamottin (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 2.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergère, M; Berjaud, C; Darmon, A; Germain, M; Levy, L; Paolini, M; Pottier, A; Poul, L; Vibert, E | 1 |
1 other study(ies) available for docetaxel anhydrous and bergamottin
| Article | Year |
|---|---|
Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.
Topics: Animals; Antineoplastic Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Docetaxel; Drug Carriers; Female; Furocoumarins; Galactosamine; Hepatocytes; Humans; Inactivation, Metabolic; Lactic Acid; Liver; Mice, Nude; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids; Tissue Distribution | 2017 |